<scp>G</scp>enetic deletion of x<scp>CT</scp> attenuates peripheral and central inflammation and mitigates <scp>LPS</scp>‐induced sickness and depressive‐like behavior in mice
-
- Yun Zhou
- Department of Molecular Medicine Institute of Basic Medical Sciences, University of Oslo Oslo 0372 Norway
-
- Sigrid Ottestad‐Hansen
- Department of Molecular Medicine Institute of Basic Medical Sciences, University of Oslo Oslo 0372 Norway
-
- Giulia Albertini
- Department of Pharmaceutical Chemistry, Drug Analysis and Drug Information Center for Neurosciences (C4N), Vrije Universiteit Brussel Brussels 1090 Belgium
-
- Gamze Ates
- Department of In Vitro Toxicology and Dermato‐cosmetology Vrije Universiteit Brussel Brussels 1090 Belgium
-
- Lauren Deneyer
- Department of Pharmaceutical Biotechnology and Molecular Biology Center for Neurosciences (C4N), Vrije Universiteit Brussel Brussels 1090 Belgium
-
- Thomas Demuyser
- Department of Pharmaceutical Chemistry, Drug Analysis and Drug Information Center for Neurosciences (C4N), Vrije Universiteit Brussel Brussels 1090 Belgium
-
- Hideyo Sato
- Laboratory of Biochemistry and Molecular Biology, Department of Medical Technology Niigata University Niigata 951‐8518 Japan
-
- Eduard Bentea
- Department of Pharmaceutical Biotechnology and Molecular Biology Center for Neurosciences (C4N), Vrije Universiteit Brussel Brussels 1090 Belgium
-
- Laura Walrave
- Department of Pharmaceutical Chemistry, Drug Analysis and Drug Information Center for Neurosciences (C4N), Vrije Universiteit Brussel Brussels 1090 Belgium
-
- Ilse Smolders
- Department of Pharmaceutical Chemistry, Drug Analysis and Drug Information Center for Neurosciences (C4N), Vrije Universiteit Brussel Brussels 1090 Belgium
-
- Niels C. Danbolt
- Department of Molecular Medicine Institute of Basic Medical Sciences, University of Oslo Oslo 0372 Norway
-
- Ann Massie
- Department of Pharmaceutical Biotechnology and Molecular Biology Center for Neurosciences (C4N), Vrije Universiteit Brussel Brussels 1090 Belgium
-
- Dimitri De Bundel
- Department of Pharmaceutical Chemistry, Drug Analysis and Drug Information Center for Neurosciences (C4N), Vrije Universiteit Brussel Brussels 1090 Belgium
書誌事項
- 公開日
- 2018-04-25
- 資源種別
- journal article
- 権利情報
-
- http://onlinelibrary.wiley.com/termsAndConditions#vor
- DOI
-
- 10.1002/glia.23343
- 公開者
- Wiley
この論文をさがす
説明
<jats:title>Abstract</jats:title><jats:p>The communication between the immune and central nervous system (CNS) is affected in many neurological disorders. Peripheral injections of the endotoxin lipopolysaccharide (LPS) are widely used to study this communication: an LPS challenge leads to a biphasic syndrome that starts with acute sickness and is followed by persistent brain inflammation and chronic behavioral alterations such as depressive‐like symptoms. <jats:italic>In vitro</jats:italic>, the response to LPS treatment has been shown to involve enhanced expression of system <jats:inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="graphic/glia23343-math-0002.png" xlink:title="urn:x-wiley:08941491:media:glia23343:glia23343-math-0002"/>. This cystine‐glutamate antiporter, with xCT as specific subunit, represents the main glial provider of extracellular glutamate in mouse hippocampus. Here we injected male xCT knockout and wildtype mice with a single intraperitoneal dose of 5 mg/kg LPS. LPS‐injection increased hippocampal xCT expression but did not alter the mainly astroglial localization of the xCT protein. Peripheral and central inflammation (as defined by cytokine levels and morphological activation of microglia) as well as LPS‐induced sickness and depressive‐like behavior were significantly attenuated in xCT‐deficient mice compared with wildtype mice. Our study is the first to demonstrate the involvement of system <jats:inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="graphic/glia23343-math-0003.png" xlink:title="urn:x-wiley:08941491:media:glia23343:glia23343-math-0003"/> in peripheral and central inflammation <jats:italic>in vivo</jats:italic> and the potential therapeutic relevance of its inhibition in brain disorders characterized by peripheral and central inflammation, such as depression.</jats:p>
収録刊行物
-
- Glia
-
Glia 66 (9), 1845-1861, 2018-04-25
Wiley
- Tweet
キーワード
- Lipopolysaccharides
- Male
- Depression/metabolism
- Amino Acid Transport System y+
- Excitatory Amino Acid Transporter 2/metabolism
- Hippocampus/metabolism
- RNA, Messenger/metabolism
- Astrocytes/metabolism
- Hippocampus
- Microglia/metabolism
- Glial Fibrillary Acidic Protein
- Illness Behavior/physiology
- Animals
- RNA, Messenger
- Amino Acid Transport System y+/deficiency
- Illness Behavior
- Inflammation
- Mice, Knockout
- Depression
- Inflammation/metabolism
- Cytokines/metabolism
- Glial Fibrillary Acidic Protein/metabolism
- Mice, Inbred C57BL
- Excitatory Amino Acid Transporter 2
- Astrocytes
- Cytokines
- Microglia
- Gene Deletion
詳細情報 詳細情報について
-
- CRID
- 1360004230121079552
-
- ISSN
- 10981136
- 08941491
-
- PubMed
- 29693305
-
- 資料種別
- journal article
-
- データソース種別
-
- Crossref
- KAKEN
- OpenAIRE
